Inrig Jula
EVP, Head of R&D & CMO
Inrig Jula has filed 8 SEC Form 4 filings (22 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Sep 18, 2026.
On the most recent filing, Inrig Jula is listed as EVP, Head of R&D & CMO at Travere Therapeutics, Inc. Inside the rolling window, Inrig Jula reported no open-market purchases and 11 open-market sales totaling $5.2M in TVTX. The largest disclosed transaction in the window is a sale of 44,674 TVTX shares on Sep 15, 2026, worth $2.8M.
Companies traded
Other insiders at TVTX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.2M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| TVTX | EVP, Head of R&D & CMO | Sale | 44,674 | $2.8M | Sep 18 | SEC ↗ | |
| TVTX | CHIEF MEDICAL OFFICER | Sale | 20,000 | $900K | May 7 | SEC ↗ | |
| TVTX | CHIEF MEDICAL OFFICER | Sale | 2,174 | $101K | May 7 | SEC ↗ | |
| TVTX | CHIEF MEDICAL OFFICER | Sale | 311 | $14K | May 7 | SEC ↗ | |
| TVTX | CHIEF MEDICAL OFFICER | Sale | 7,215 | $303K | Apr 15 | SEC ↗ | |
| TVTX | CHIEF MEDICAL OFFICER | Sale | 1,018 | $43K | Apr 15 | SEC ↗ | |
| TVTX | CHIEF MEDICAL OFFICER | Sale | 1,779 | $57K | Feb 5 | SEC ↗ | |
| TVTX | CHIEF MEDICAL OFFICER | Sale | 6,956 | $223K | Feb 3 | SEC ↗ | |
| TVTX | CHIEF MEDICAL OFFICER | Sale | 2,031 | $82K | Jan 7 | SEC ↗ | |
| TVTX | CHIEF MEDICAL OFFICER | Sale | 445 | $17K | Jan 7 | SEC ↗ | |
| TVTX | CHIEF MEDICAL OFFICER | Sale | 15,000 | $630K | Dec 29 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 filings has Inrig Jula made?
Inrig Jula has filed 8 SEC Form 4 filings (22 transaction rows) across 1 company since 2025.
Which companies does Inrig Jula trade?
Inrig Jula has filed SEC Form 4 disclosures for 1 company, including TVTX.
When was Inrig Jula's most recent SEC Form 4 filing?
Inrig Jula's most recent SEC Form 4 filing on Tracefour is dated Sep 18, 2026.
What is Inrig Jula's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Inrig Jula is listed as EVP, Head of R&D & CMO.
What is Inrig Jula's total buy and sell value in the current window?
Inside the rolling retention window, Inrig Jula bought $0 and sold $5.2M based on SEC Form 4 filings.
What was Inrig Jula's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 44,674 TVTX shares on 2026-09-15, worth $2.8M, per SEC Form 4 filings.